Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.
Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.
Google News